Preview
  • Unnecessary Expense

  • An Antidote for the Billion Dollar Drug Problem
  • By: Charles Theuer
  • Narrated by: TJ Oberholzer
  • Length: 3 hrs and 58 mins

Prime logo Prime members: New to Audible?
Get 2 free audiobooks during trial.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 30 days. Cancel anytime.

Unnecessary Expense

By: Charles Theuer
Narrated by: TJ Oberholzer
Try for $0.00

$14.95/month after 30 days. Cancel anytime.

Buy for $14.95

Buy for $14.95

Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.

Publisher's summary

The drug development process in the United States has become so weighted down by a business-as-usual paradigm that an average of more than two billion dollars is spent to secure FDA approval for every new drug. Because the investment required is so extreme, drug development companies are understandably focused on discovering and developing drugs designed for large patient populations: diseases experienced by millions, such as high blood pressure, diabetes, or some of the more common cancers.

In Unnecessary Expense, Dr. Charles Theuer, CEO of TRACON Pharmaceuticals, outlines the problem and offers a solution: an aligned and streamlined model that emphasizes quality and reduces the time and cost of drug development, while also harnessing global innovation to benefit patients with rare diseases in urgent need of new treatments. Here Dr. Theuer shows the value of a pharmaceutical paradigm shift, to enable the development of drugs for patients who need them, at a fraction of the time and cost.

©2021 Charles Theuer (P)2021 Charles Theuer
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Unnecessary Expense

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.